Research to Assess Impact of Equine-Assisted Services on Trauma Survivors

The Human Animal Bond Research Institute (HABRI) announced today the online publication of a study titled, “The Effect of a PTSD Service Dog on Military Veterans’ Medication Regimens: A Cross-Sectional Pilot Study”, in the journal Anthrozoos. Findings of the study, conducted by researchers at the Purdue University College of Veterinary Medicine and the Purdue University College of Pharmacy, found no significant differences between post-9/11 U.S. veterans living with post-traumatic stress disorder (PTSD) who were provided with a psychiatric service dog and veterans on a waitlist to receive a service dog in terms of number and type of medications reported. However, veterans with a service dog were more likely to report that their doctor had decreased dosage or removed medications, as compared to veterans on the waitlist to acquire a service dog. “Our previous research has found that PTSD service dogs can improve specific areas of functioning and symptomology for military veterans. This new research builds on these findings by exploring how PTSD service dogs impact veterans’ medication use,” said study co-author Dr. Kerri Rodriguez, Postdoctoral Researcher at Colorado State University. “These results indicate that PTSD service dogs played a positive supporting role. Veterans kept up with their medication regimens, indicating that the presence of the service dog was not associated with any lapse in standard treatment. While having a PTSD service dog may not completely alleviate veterans’ needs for sleep, pain, or anxiety medications, there were reported decreases in dosage levels, shedding additional light on the potential value of these service dogs as a complimentary intervention.” The objective of this study was to quantify the effect of PTSD service dogs on medication use among a population of military veterans with PTSD. Fifty-two veterans living with a PTSD service dog and 44 veterans on a waitlist to receive a service dog were recruited from a database...

The Human Animal Bond Research Institute (HABRI) announced today that Treat Planet, makers of natural, eco-friendly pet products, has become an official supporter of HABRI and its research on the human health benefits of companion animals. “As makers of the best darn treats on the planet, Treat Planet provides man’s best friend with the best quality nutrition to keep them healthy and happy,” said Doug Martin, President of Treat Planet. “HABRI’s research shows that by maintaining a pet’s health, pet owners can improve their own health and well-being. Through supporting HABRI, Treat Planet is now advancing the human-animal bond through scientific research and quality nutrition, and we couldn’t be more proud.” “Recent HABRI research found that when educated about the health benefits of the human-animal bond, pet owners are more likely to provide their pets with higher quality nutrition, including treats,” said Steven Feldman, Executive Director of HABRI. “Not only is Treat Planet furthering its own mission through joining other leading companies and organizations from the pet care community that support HABRI, but it’s also contributing to a broader purpose of ensuring that more people can improve their health and quality of life through pet ownership.” Scientific evidence increasingly shows that pets improve heart health; alleviate depression; increase well-being; support child health and development; and contribute to healthy aging. In addition, companion animals can assist in the treatment of a broad range of conditions from post-traumatic stress to Alzheimer’s disease to autism spectrum disorder. The benefits of the human-animal bond impact more than just human health. Findings from a recent HABRI survey of 2,000 pet owners demonstrate that knowledge of the scientific research on the human-animal bond motivates pet owners to take better care of their pets. From providing pets with higher quality nutrition to more frequent visits to the...

The North American Veterinary Community (NAVC) and the Human Animal Bond Research Institute (HABRI), who jointly founded the Human-Animal Bond Certification program last year, announced today that Zoetis, a leading animal health company, has become the first Human-Animal Bond Certified Company. “With its long-term commitment to funding human-animal bond research, education, professional development and programming, Zoetis is uniquely deserving of this meaningful recognition,” said Steven Feldman, HABRI Executive Director. “Being a Human-Animal Bond Certified Company sends a clear message that Zoetis is a leader in strengthening the human-animal bond for the veterinary community and the public.” “For years, Zoetis has been a leading advocate of the bond between humans and animals, and we are honored to have earned this important certification,” said J. Michael McFarland, DVM, DABVP, Executive Director, Zoetis Petcare Marketing and Chair of the HABRI Board of Trustees. “Veterinarians play a key role in strengthening the relationship between animals and people, and Zoetis is committed to helping them, their clients, and the animals they care for experience the benefits of the human-animal bond.” As part of the certification process, more than two dozen Zoetis employees successfully completed the certification program, receiving training on the science behind the human-animal bond and developing a deep understanding of how this science supports the practice of veterinary medicine. Zoetis is committed to ongoing training for additional employees. The leadership role of Zoetis is evidenced by its commitment to education, and the company was an early supporter of the Human-Animal Bond Certification program. After only one year, more than 500 professionals have signed up for this certification, which offers 22 hours of RACE-approved continuing education credit. Zoetis has also developed educational resources surrounding the bond for its own employees, for the...